TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biotage AB
Closing information (x1000 DKK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
1,335,286
|
1,250,658
|
1,046,453 |
| Financial expenses |
43,514
|
27,539
|
9,355 |
| Earnings before taxes |
213,022
|
203,517
|
232,545 |
| EBITDA |
368,892
|
310,985
|
286,672 |
| Total assets |
3,314,834
|
3,312,027
|
1,562,998 |
| Current assets |
881,964
|
971,913
|
688,948 |
| Current liabilities |
375,387
|
470,844
|
276,649 |
| Equity capital |
2,671,221
|
2,456,314
|
1,093,898 |
| - share capital |
73,389
|
75,228
|
62,146 |
| Employees (average) |
673
|
674
|
517 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
80.6%
|
74.2%
|
70.0% |
| Turnover per employee |
1,984
|
1,856
|
2,024 |
| Profit as a percentage of turnover |
16.0%
|
16.3%
|
22.2% |
| Return on assets (ROA) |
7.7%
|
7.0%
|
15.5% |
| Current ratio |
234.9%
|
206.4%
|
249.0% |
| Return on equity (ROE) |
8.0%
|
8.3%
|
21.3% |
| Change turnover |
125,995
|
198,816
|
223,190 |
| Change turnover % |
10%
|
19%
|
27% |
| Chg. No. of employees |
-1
|
157
|
20 |
| Chg. No. of employees % |
0%
|
30%
|
4% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.